Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in RELAY THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 209,848 shares of RLAY (RELAY THERAPEUTICS INC), worth $1.8M as of 2025-Q4. The position was increased (++3.8% shares). RLAY represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$1.8M
Current Shares
209,848
Total Value Change
+$408,402
Total Shares Change
+199
Other major holders of RLAY: BNP PARIBAS FINANCIAL MARKETS, SB INVESTMENT ADVISERS (UK) LTD
Increased |
| 209,848 |
+3.8% |
| $1.8M |
| 0.0% |
| $8.35 |
27 |
| 2025-Q3 | Decreased | 202,244 | -50.5% | $1.1M | 0.0% | $5.19 | 0 |
| 2025-Q2 | Increased | 408,902 | +35.6% | $1.4M | 0.0% | $3.30 | 33 |
| 2025-Q1 | Increased | 301,550 | +29.6% | $790,060 | 0.0% | $2.72 | 31 |
| 2024-Q4 | Increased | 232,582 | +4.2% | $958,238 | 0.0% | $4.18 | 26 |
| 2024-Q3 | Increased | 223,289 | +6.5% | $1.6M | 0.0% | $7.46 | 27 |
| 2024-Q2 | Decreased | 209,649 | -62.4% | $1.4M | 0.0% | $6.52 | 0 |